Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jun;45(6):1889-92.
doi: 10.1128/JCM.02392-06. Epub 2007 Mar 14.

Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method

Shumei Zou  1 , Jian Han, Leying Wen, Yan Liu, Kassi Cronin, Shanjuan H Lum, Lu Gao, Jie Dong, Ye Zhang, Yuanji Guo, Yuelong Shu
Affiliations

Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method

Shumei Zou et al. J Clin Microbiol. 2007 Jun.

Abstract

We report the use of ResPlex III for genotyping influenza A viruses. The performance characteristics of the assay with regard to H5N1 are further evaluated. The ResPlex system incorporates a novel multiplex PCR technology, target-enriched multiplex PCR, to simultaneously amplify multiple molecular targets in one reaction. The ResPlex III assay targets the H1, H2, H3, H5, H7, H9, N1, and N2 genes from the influenza A virus as well as the NS genes from influenza A (NSA) and B (NSB) viruses, providing detection and genotyping of influenza A and B viruses. The analytical sensitivities for detecting the H5, N1, and NSA genes were 1, 10(-1), and 10 50% tissue culture infectious doses/200 microl/reaction, respectively. A total of 217 sequential clinical samples including 14 samples with human H5N1 infections were tested by the ResPlex III assay, and the results were compared to a reference standard combined with results of viral culture and conventional reverse transcriptase and real-time PCR. The clinical sensitivity and specificity for detecting H5N1 were 93.3% and 100%, respectively, indicating that different subtypes of influenza A virus can be quickly and correctly identified using the ResPlex III genotyping approach.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Representative results of ResPlex III genotyping analysis.
See this image and copyright information in PMC

References

    1. Brunstein, J., and E. Thomas. 2006. Direct screening of clinical specimens for multiple respiratory pathogens using the Genaco respiratory panels I & II. Diagn. Mol. Pathol. 15:169-173. - PubMed
    1. Centers for Disease Control and Prevention. 2006. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). Morb. Mortal. Wkly. Rep. 55:127. - PubMed
    1. Dunbar, S. A., C. A. Vander Zee, K. G. Oliver, K. L. Karem, and J. W. Jacobson. 2003. Quantitative, multiplexed detection of bacterial pathogens: DNA and protein applications of the Luminex LabMap system. J. Microbiol. Methods 53:245-252. - PubMed
    1. Guo, Y. J., and X. W. Cheng. 1997. Laboratory techniques for influenza studies. SanXia Publishing, Beijing, People's Republic of China.
    1. Han, J. 2006. Molecular differential diagnoses of infectious diseases: is the future now? In C. Stratton and Y. W. Tang (ed.), Advanced technologies in diagnostic microbiology. Springer Publishing Company, New York, NY.

Publication types

MeSH terms

Substances